Created in 2017, the STROK@LLIANCE brand has quickly built a reputation for quality and success in the field of preclinical services in neurology. It is a real pleasure for us to see our brand building value. Having already secured trademark protection in Europe, ETAP-Lab is proud to announce that the Japanese patent office has now […]

For several years now, Prof. Denis Vivien’s team (Laboratoire PhIND, U1237, Caen), our STROK@LLIANCE partner, has been looking into in the potential of N-Acetylcysteine (NAC, Mucomyst®) for thrombolysis of resistant clots during the acute phase of ischemic stroke. While this old molecule is well known as a bronchial fluidizer, it is not generally thought of […]

STROK@LLIANCE will participate to MEDICA next 19 November in Dusseldorf. Our expert Dr. Nicolas Violle (CEO) will present Strok@lliance’s services in the field of stroke preclinical research. Our partner CYCERON, represented by Dr. Benoit Haelewyn, will also be present during this event. By taking advantage of the CYCERON facilities, STROK@LLIANCE accesses such cutting-edge technologies as […]